Work

A Single-Center Phase IIa Study Evaluating the Safety and Tolerability of Umbralisib and Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-119765

Authors: Matthew A. Lunning, Philip Bierman, R. Gregory Bociek, James O. Armitage, Peggy Heires, Maribeth Hohenstein, Susan Blumel, Jonathan Tefft, Elizabeth R. Lyden, Michael R Green, Julie M. Vose

Institution: University of Nebraska Medical Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2981009312

Cites:

Cited by:

Related to: 10